| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Reg IDCW |
| [Equity: Index] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
0.13 |
| Equity |
69.55 |
| Int Equity |
30.27 |
| Trep |
0.05 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
34.38% |
| Top 10 Holdings |
55.63% |
| Top 25 Holdings |
85.91% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
53.34 |
| Global Equity |
30.27 |
| Healthcare |
16.21 |
| Cash |
0.18 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
96.41 |
| PE Ratio |
720.42 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Sun Pharmaceutical Industries Ltd. |
11.30 |
| ELI LILLY & CO |
6.43 |
| Divis Laboratories Ltd. |
6.07 |
| Apollo Hospitals Enterprises Ltd. |
5.69 |
| Max Healthcare Institute Limited |
4.89 |
| Cipla Ltd. |
4.69 |
| Torrent Pharmaceuticals Ltd. |
4.61 |
| JOHNSON & JOHNSON |
4.30 |
| Laurus Labs Limited |
4.02 |
| Dr. Reddys Laboratories Ltd. |
3.63 |
| Lupin Ltd |
3.48 |
| ABBVIE INC |
3.09 |
| Fortis Healthcare Ltd |
2.93 |
| Aurobindo Pharma Ltd. |
2.61 |
| Merck & Co. Inc |
2.24 |
| Glenmark Pharmaceuticals ltd |
1.99 |
| NOVARTIS AG |
1.99 |
| Biocon Ltd. |
1.74 |
| Mankind Pharma Limited |
1.61 |
| Ipca Laboratories Ltd. |
1.54 |
| Alkem Laboratories Limited |
1.52 |
| THERMO FISHER SCIENTIFIC INC |
1.49 |
| AMGEN INC |
1.45 |
| Zydus Lifesciences Limited |
1.32 |
| ABBOTT LABORATORIES |
1.28 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|